ROHAN PALEKAR
CIK 1423327 · Chief Executive Officer · last filed 2026-02-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
60
Lifetime Open-Market Net
-$3.95M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NGNE | Director | — | $29.10 | — | $0 | 4 | 2026-02-24 |
| 89bio, Inc. (ETNB) Delisted | Chief Executive Officer | 0 | $14.84 | $0 | -$1.43M | 31 | 2025-10-30 |
| Neurogene Inc. (NLTX) Delisted | Director | — | $13.96 | — | $0 | 3 | 2023-06-09 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | SVP & Chief Commercial Officer | 302,806 | — | — | -$418.0K | 10 | 2014-11-28 |
| MEDIVATION, INC. (MDVN) Delisted | Chief Commercial Officer | 16,666 | — | — | -$2.10M | 12 | 2011-04-21 |
Recent Filings · Page 2 of 6
60 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-17 | NGNE | Grant (A) | — | $0 | EDGAR |
| 2024-04-03 | 89bio, Inc. (ETNB) Delisted | Mixed | −27,718 | -$526.9K | EDGAR |
| 2024-02-28 | 89bio, Inc. (ETNB) Delisted | Sell (S) | −4,477 | -$48.2K | EDGAR |
| 2024-02-23 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −4,602 | -$44.8K | EDGAR |
| 2024-02-13 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −12,670 | -$107.1K | EDGAR |
| 2024-02-05 | 89bio, Inc. (ETNB) Delisted | Mixed | +144,932 | -$49.7K | EDGAR |
| 2024-01-18 | NGNE | Grant (A) | — | $0 | EDGAR |
| 2024-01-08 | 89bio, Inc. (ETNB) Delisted | Mixed | +47,489 | -$317.2K | EDGAR |
| 2024-01-03 | 89bio, Inc. (ETNB) Delisted | Mixed | — | -$463.5K | EDGAR |
| 2023-08-21 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −4,501 | -$69.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.